Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. The vast majority of revenue comes from the scientific instruments segment, which develops tools based on magnetic resonance, mass spectrometry, and X-ray technologies. The remainder of the firm's business comes from the energy and superconductor technology segment, which manufactures superconducting materials primarily used in magnetic resonance imaging, nuclear magnetic resonance, and fusion energy research. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia.
| Website: | www.bruker.com |
| Email: | investor.relations@bruker.com |
| Main Phone: | +1 978 663-3660 |
| Address: | 40 Manning Road |
| State: | MA |
| City / Town: | Billerica |
| Country: | USA |
| Postal Code: | 01821 |
| Exchange: | NGS |
| CEO: | Frank H. Laukien |
| Employees: | 6870 |
| NAICS: | Analytical Laboratory Instrument Manufacturing(334516) |
Gathering Data... Please wait Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. The vast majority of revenue comes from the scientific instruments segment, which develops tools based on magnetic resonance, mass spectrometry, and X-ray technologies. The remainder of the firm's business comes from the energy and superconductor technology segment, which manufactures superconducting materials primarily used in magnetic resonance imaging, nuclear magnetic resonance, and fusion energy research. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia.
| Website: | www.bruker.com |
| Email: | investor.relations@bruker.com |
| Main Phone: | +1 978 663-3660 |
| Address: | 40 Manning Road |
| State: | MA |
| City / Town: | Billerica |
| Country: | USA |
| Postal Code: | 01821 |
| Exchange: | NGS |
| CEO: | Frank H. Laukien |
| Employees: | 6870 |
| NAICS: | Analytical Laboratory Instrument Manufacturing(334516) |
| Last Price 41.37 | Change $ -1.05 | Change % -2.48 | Tick N/A |
| Bid 29.99 | Bid Size 100.00 | Ask 47.91 | Ask Size 100.00 |
| Open 42.10 | High 42.38 | Low 41.33 | Prev Close 42.42 |
| Last Trade | Volume 399,535 | 52 Wk Hi 44.47 | 52 Wk Low 26.10 |
| Market Cap 6.5 bi | Ex-Div Date | Div Rate 0.16 | Yield 0.3870 |
| Shares 156,816,577.00 | EPS (TTM) 1.17 | PE Ratio 35.40 | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 1 | 25 |
| Number of Buys | 0 | 19 |
| Number of Sells | 1 | 6 |
| Net Activity | -1384 | 184342 |
| Last 10 Buys | Shares |
|---|---|
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Frank H. Laukien | 1,000 |
| Richard A. Packer | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Mark Munch | 1,000 |
| Chris van Ingen | 1,000 |
| Richard D. Kniss | 1,000 |
| Mark Munch | 1,000 |
| Chris van Ingen | 1,000 |
| Joerg C. Laukien | 1,000 |
| Wolf-Dieter Emmerich | 1,000 |
| Brenda J. Furlong | 1,000 |
| Mark Munch | 1,000 |
| Joerg C. Laukien | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 38 | 38 | 38 | 38 |
| Low Target Price Estimate | 31 | 31 | 31 | 31 |
| Mean Target Price Estimate | 34.3 | 34.3 | 34.3 | 34.3 |
| Standard Deviation | 2 | 2 | 2 | 2 |
| Date of Most Recent Estimate | 06/01/18 | 05/04/18 | 05/04/18 | 06/01/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-19 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-06-06 |
| SD | Specialized Disclosure Report | 15 | 2018-05-31 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-05-21 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 55 | 2018-05-10 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-05-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 11 | 2018-05-03 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 67 | 2018-04-17 |
| 10-K | Annual report with a comprehensive overview of the company | 149 | 2018-03-16 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 10 | 10 | 10 | 10 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 1 |
| Mean Rec. | 2.67 | 2.67 | 2.67 | 2.85 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
